Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

1. Porta-Etessam, J.
2. González-García, N.
3. Guerrero, Á.L.
4. García-Azorín, D.

Exportar

Exportar

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar

×

Non se pode exportar o documento porque pertence a outro portal.

Texto completo

lock_openTexto completo externo

DOI: 10.1016/J.NRL.2020.10.009 GOOGLE SCHOLAR lock_openAcceso aberto editor